After Latter Announced Resmetirom Achieved Both Primary Endpoints in NASH And Liver Fibrosis Trial
https://www.benzinga.com/news/22/12/30125869/viking-therapeutics-shares-spike-higher-premarket-in-sympathy-with-madrigal-pharmaceuticals-which-ga
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.